留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

促红细胞生成素预处理增强大鼠骨髓间充质干细胞定向归巢能力的初步研究

乔禹铭 周松 张亚 刘永光 赵明

乔禹铭, 周松, 张亚, 等. 促红细胞生成素预处理增强大鼠骨髓间充质干细胞定向归巢能力的初步研究[J]. 器官移植, 2021, 12(1): 57-63. doi: 10.3969/j.issn.1674-7445.2021.01.009
引用本文: 乔禹铭, 周松, 张亚, 等. 促红细胞生成素预处理增强大鼠骨髓间充质干细胞定向归巢能力的初步研究[J]. 器官移植, 2021, 12(1): 57-63. doi: 10.3969/j.issn.1674-7445.2021.01.009
Qiao Yuming, Zhou Song, Zhang Ya, et al. Preliminary study of effect of erythropoietin pretreatment on enhancing directional homing ability of bone marrow mesenchymal stem cells in rats[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 57-63. doi: 10.3969/j.issn.1674-7445.2021.01.009
Citation: Qiao Yuming, Zhou Song, Zhang Ya, et al. Preliminary study of effect of erythropoietin pretreatment on enhancing directional homing ability of bone marrow mesenchymal stem cells in rats[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 57-63. doi: 10.3969/j.issn.1674-7445.2021.01.009

促红细胞生成素预处理增强大鼠骨髓间充质干细胞定向归巢能力的初步研究

doi: 10.3969/j.issn.1674-7445.2021.01.009
基金项目: 

广东省科技计划项目 2016A020220014

详细信息
    作者简介:

    乔禹铭,男,1993年生,硕士研究生,研究方向为移植免疫,Email:458033778@qq.com

    通讯作者:

    赵明,男,1962年生,博士,主任医师,研究方向为移植免疫,Email:zhaoming02@hotmail.com

  • 中图分类号: R617

Preliminary study of effect of erythropoietin pretreatment on enhancing directional homing ability of bone marrow mesenchymal stem cells in rats

More Information
  • 摘要:   目的  探讨促红细胞生成素(EPO)对大鼠骨髓间充质干细胞(BMSC)增殖及迁移能力的影响。  方法  将第5代BMSC分为5组,分别为对照组(不加EPO)及10、100、500、1 000 IU/mL EPO组,培养24 h和48 h后检测各组BMSC的增殖率、迁移能力以及趋化因子受体(CXCR)4的表达情况。将第5代BMSC分为BMSC组和EPO-BMSC组,培养48 h后观察EPO对两组BMSC的表面标志物、定向分化和细胞骨架形态的影响。  结果  EPO与BMSC共培养48 h后,与对照组比较,100、500 IU/mL EPO组BMSC增殖率和迁移能力增强,CXCR4蛋白表达量增高(均为P < 0.05)。EPO-BMSC组BMSC表面标志物的表达和定向分化能力未受EPO影响。在EPO-BMSC组中,大多数细胞的纤维骨架沿细胞的长轴排列,呈平行状。  结论  EPO可提高BMSC的增殖率、迁移能力和组织修复治疗能力,可能通过增加CXCR4的表达,促进其向损伤器官组织的定向归巢。

     

  • 图  1  EPO对BMSC增殖率的影响

    注:与对照组比较,aP < 0.05;与100 IU/mL EPO组比较,bP < 0.05。

    Figure  1.  Effects of EPO on proliferation rate of BMSC

    图  2  EPO对BMSC迁移能力的影响(×100)

    注:A图为空白对照,B图为对照组;C~F图分别为10、100、500、1 000 IU/mL EPO组。

    Figure  2.  Effects of EPO on migration of BMSC

    图  3  EPO对BMSC中CXCR4表达水平的影响

    注:与对照组比较,aP < 0.05;与100 IU/mL EPO组比较,bP < 0.05。

    Figure  3.  Effects of EPO on CXCR4 expression level in BMSC

    图  4  EPO对BMSC表面标志物表达的影响

    注:A~C图为BMSC组BMSC表面标志物表达情况;D~F图为EPO-BMSC组BMSC表面标志物表达情况。

    Figure  4.  Effects of EPO on expression of surface markers of BMSC

    图  5  EPO对BMSC定向分化的影响

    注:A、B图分别为BMSC组和EPO-BMSC组的成骨诱导结果(硝酸银,×100);C、D图分别为BMSC组和EPO-BMSC组的成脂诱导结果(油红O,×100)。

    Figure  5.  Effects of EPO on directional differentiation of BMSC

    图  6  EPO对BMSC细胞骨架形态的影响(免疫荧光,×400)

    注:A~C图为BMSC组,微管染色、微丝染色呈杂乱状;D~F图为EPO-BMSC组,微管、微丝染色呈平行状。

    Figure  6.  Effects of EPO on cytoskeletal morphology of BMSC

  • [1] JIANG W, XU J. Immune modulation by mesenchymal stem cells[J]. Cell Prolif, 2020, 53(1):e12712. DOI: 10.1111/cpr.12712.
    [2] 曲泽澎, 贾兆锋, 黄曦, 等.间充质干细胞在器官移植中的应用研究进展[J].器官移植, 2018, 9(5):348-353. DOI: 10.3969/j.issn.1674-7445.2018.05.005.

    QU ZP, JIA ZF, HUANG X, et al. Research progress of the application of mesenchymal stem cells in organ transplantation[J]. Organ Transplant, 2018, 9(5):348-353. DOI: 10.3969/j.issn.1674-7445.2018.05.005.
    [3] GLEESON BM, MARTIN K, ALI MT, et al. Bone marrow-derived mesenchymal stem cells have innate procoagulant activity and cause microvascular obstruction following intracoronary delivery: amelioration by antithrombin therapy[J]. Stem Cells, 2015, 33(9):2726-2737. DOI: 10.1002/stem.2050.
    [4] PEIRED AJ, SISTI A, ROMAGNANI P. Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence[J]. Stem Cells Int, 2016:4798639. DOI: 10.1155/2016/4798639.
    [5] FAN H, ZHAO G, LIU L, et al. Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis[J]. Cell Mol Immunol, 2012, 9(6):473-481. DOI: 10.1038/cmi.2012.40.
    [6] WANG S, ZHANG C, NIYAZI S, et al. A novel cytoprotective peptide protects mesenchymal stem cells against mitochondrial dysfunction and apoptosis induced by starvation via Nrf2/Sirt3/FoxO3a pathway[J]. J Transl Med, 2017, 15(1):33. DOI: 10.1186/s12967-017-1144-5.
    [7] LISOWSKA KA, DEBSKA-SLIZIEŃ A, BRYL E, et al. Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment[J]. Artif Organs, 2010, 34(8):654-662. DOI: 10.1111/j.1525-1594.2009.00948.x.
    [8] GENC S, KOROGLU TF, GENC K. Erythropoietin as a novel neuroprotectant[J]. Restor Neurol Neurosci, 2004, 22(2):105-119.
    [9] CUI L, GUO J, ZHANG Q, et al. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity[J]. Toxicol Lett, 2017, 275:28-38. DOI: 10.1016/j.toxlet.2017.04.018.
    [10] ZWEZDARYK KJ, COFFELT SB, FIGUEROA YG, et al. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells[J]. Exp Hematol, 2007, 35(4):640-652. DOI: 10.1016/j.exphem.2007.01.044.
    [11] WU J, ZHANG W, RAN Q, et al. The differentiation balance of bone marrow mesenchymal stem cells is crucial to hematopoiesis[J]. Stem Cells Int, 2018:1540148. DOI: 10.1155/2018/1540148.
    [12] 李婷, 陈莉智, 黄文华.骨髓间充质干细胞在基础医学及临床应用中的研究进展[J].中国医学物理学杂志, 2019, 36(8):962-967. DOI:10.3969/j.issn.1005-202X. 2019.08.019.

    LI T, CHEN LZ, HUANG WH. Research progress on bone marrow mesenchymal stem cells in basic medicine and clinical application[J]. Chin J Med Physic, 2019, 36(8):962-967. DOI:10.3969/j.issn.1005-202X. 2019. 08.019.
    [13] PETERBAUER-SCHERB A, VAN GRIENSVEN M, MEINL A, et al. Isolation of pig bone marrow mesenchymal stem cells suitable for one-step procedures in chondrogenic regeneration[J]. J Tissue Eng Regen Med, 2010, 4(6):485-490. DOI: 10.1002/term.262.
    [14] DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. the International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317. DOI: 10.1080/14653240600855905.
    [15] 徐璐, 马俊杰, 陈正, 等.骨髓间充质干细胞在亲属活体肾移植中的临床应用研究[C]//中华医学会.2012中国器官移植大会论文集.
    [16] LIU N, WANG H, HAN G, et al. Alleviation of apoptosis of bone marrow-derived mesenchymal stem cells in the acute injured kidney by heme oxygenase-1 gene modification[J]. Int J Biochem Cell Biol, 2015, 69:85-94. DOI: 10.1016/j.biocel.2015.10.007.
    [17] KARP JM, LENG TEO GS. Mesenchymal stem cell homing: the devil is in the details[J]. Cell Stem Cell, 2009, 4(3):206-216. DOI: 10.1016/j.stem.2009.02.001.
    [18] HAN J, FENG Z, XIE Y, et al. Oncostatin M-induced upregulation of SDF-1 improves bone marrow stromal cell migration in a rat middle cerebral artery occlusion stroke model[J]. Exp Neurol, 2019, 313:49-59. DOI: 10.1016/j.expneurol.2018.09.005.
    [19] 段亚妮, 木拉提·阿比来列提, 朱雁秋, 等.LncRNA Xist通过调控SDF-1/CXCR4轴促进大鼠骨髓间充质干细胞增殖与迁移[J].中山大学学报(医学科学版), 2020, 41(1):37-43. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK202001007.htm

    DUAN YN, MULATI ABLLT, ZHU YQ, et al. LncRNA Xist promotes proliferation and migration of rat BMSC by regulating CXCR4 expression[J]. J Sun Yat-sen Univ (Med Sci), 2020, 41(1):37-43. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK202001007.htm
    [20] CHEN Z, CHEN Q, DU H, et al. Mesenchymal stem cells and CXC chemokine receptor 4 overexpression improved the therapeutic effect on colitis via mucosa repair[J]. Exp Ther Med, 2018, 16(2):821-829. DOI: 10.3892/etm.2018.6233.
    [21] GUO K, YAO X, WU W, et al. HIF-1α/SDF-1/CXCR4 axis reduces neuronal apoptosis via enhancing the bone marrow-derived mesenchymal stromal cell migration in rats with traumatic brain injury[J]. Exp Mol Pathol, 2020, 114:104416. DOI: 10.1016/j.yexmp.2020.104416.
    [22] XINARIS C, MORIGI M, BENEDETTI V, et al. A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion[J]. Cell Transplant, 2013, 22(3):423-436. DOI: 10.3727/096368912X653246.
    [23] IMPELLIZZIERI D, RIDDER F, RAEBER ME, et al. IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation[J].J Allergy Clin Immunol, 2019, 144(1):267-279. DOI: 10.1016/j.jaci.2019.01.042.
    [24] LIU N, TIAN J, CHENG J, et al. Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment[J]. Exp Cell Res, 2013, 319(13):2019-2027. DOI: 10.1016/j.yexcr.2013.04.008.
    [25] 李正章, 沈哲, 程应樟, 等.促红细胞生成素影响骨髓间充质干细胞增殖的量效关系[J].中国组织工程研究与临床康复, 2011, 15(49):9133-9136. DOI: 10.3969/j.issn.1673-8225.2011.49.003.

    LI ZZ, SHEN Z, CHENG YZ, et al. Dose-dependent effect of erythropoietin on the proliferation of rabbit bone marrow mesenchymal stem cells[J]. Chin J Tissue Eng Res, 2011, 15(49):9133-9136. DOI: 10.3969/j.issn.1673-8225.2011.49.003.
    [26] 吴燕丽, 毕小军, 宫晨, 等.机械生长因子对骨髓间充质干细胞迁移作用的影响及相关机制研究[J].中华物理医学与康复杂志, 2018, 40(8):569-574. DOI: 10.3760/cma.j.issn.0254-1424.2018.08.003.

    WU YL, BI XJ, GONG C, et al. Mechano growth factor promotes the migration of bone marrow-derived mesenchymal stem cells[J]. Chin J Phy Med Rehab, 2018, 40(8):569-574. DOI: 10.3760/cma.j.issn.0254-1424.2018.08.003.
  • 加载中
图(6)
计量
  • 文章访问数:  234
  • HTML全文浏览量:  59
  • PDF下载量:  21
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-09-13
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2021-01-19

目录

    /

    返回文章
    返回